Law firms Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’ Sophie Chan · 9 February 2024 · 4 min read Profile Life Sciences Yearbook 2024 Baker McKenzie’s Jaspreet Takhar on the future of digital health solutionsWhat made you decide to specialise in life sciences law? This article is for Legal Business subscribers. Please log in or subscribe to read on. Related ContentMore in this categoryM&A perspectives: Melissa FogartyLaw firmsIman Tribak26 Jun 2024M&A perspectives: Jennifer BethlehemLaw firmsIman Tribak26 Jun 2024M&A perspectives: Lorenzo CorteLaw firmsIman Tribak26 Jun 2024Sponsored thought leadership: China life sciences – Transaction insights and notable industry trendsPractice areasGuest Blog9 Feb 2024The Legal 500 view: Healthy competitionLaw firmsBen Wheway9 Feb 2024Life Sciences Yearbook 2024 – Editor’s letterPractice areasGeorgina Stanley9 Feb 2024Transatlantic firms outstrip peers on five-year PEP growth, LB100 data revealsLaw firmsAlex Ryan20 Dec 2024A good time to be mid-tier: private equity interest on the rise as mid-market thrivesLaw firmsTom Cox18 Dec 2024The LB100 ranked by PEP: firms push partner profits to new heights as associate pay debate rumbles onLaw firmsAlex Ryan18 Dec 2024